Vidcare Technologies raises $300,000 in pre-seed funding
- ByStartupStory | August 25, 2022
Vidcare Technologies, a platform for point-of-care and consumer diagnostic testing, has secured $300,000 in a pre-Seed funding round headed by Social Alpha. Lavni Ventures and the Derbi Foundation also participated in the financing.
“This fresh round of funding will be utilized to continue product development and commercialization following regulatory clearances, as well as work on future applications based on this technology. Our goal is to leverage the Mu-sure platform to develop diagnostic tests that will make a wide range of high-quality diagnostics more accessible to both urban and rural locations “Vidcare’s founder, Rohan Aggarwal, stated.Vidcare has been able to eliminate the need for any additional device or attachment to offer quantifiable results, which is a significant technological achievement in the field of point-of-care diagnostics.
“We are optimistic about the future of diagnostic medicine, particularly in the field of point-of-care diagnostics, at Social Alpha. We are seeing a progressive increase in the decentralization of laboratory tests, which implies that tests and analyses are being performed at the patient’s bedside, in-clinic, or home by the patients themselves. Vidcare’s scalable platform will generate a portfolio of precise, user-friendly point-of-care quantitative tests for monitoring health and chronic illnesses “Kshama Kothari, director of Social Alpha, agreed.
About Vidcare Technologies
Founded in 2017 by Rohan Aggarwal, Karan Aggarwal, and Saurabh Kumar Srivastava, Vidcare Technologies developing an equipment-free, stand-alone, quantitative immunoassay chip, that can be used in resource constrained environments. Their envision to bring healthcare to the doorstep, without compromising on quality.
Follow Startup Story
Related Posts
